238 related articles for article (PubMed ID: 24808948)
1. Transoral Robotic Surgery in the HPV Era.
Duek I; Billan S; Amit M; Gil Z
Rambam Maimonides Med J; 2014 Apr; 5(2):e0010. PubMed ID: 24808948
[TBL] [Abstract][Full Text] [Related]
2. The role of transoral robotic surgery in the management of oropharyngeal squamous cell carcinoma: a current review.
Sansoni ER; Gross ND
Curr Oncol Rep; 2015 Mar; 17(3):432. PubMed ID: 25687805
[TBL] [Abstract][Full Text] [Related]
3. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
[TBL] [Abstract][Full Text] [Related]
4. The role of transoral robotic surgery in the management of oropharyngeal cancer.
Dias FL; Walder F; Leonhardt FD
Curr Opin Oncol; 2017 May; 29(3):166-171. PubMed ID: 28252460
[TBL] [Abstract][Full Text] [Related]
5. The Role of Transoral Robotic Surgery in the Management of HPV Negative Oropharyngeal Squamous Cell Carcinoma.
Sload R; Silver N; Jawad BA; Gross ND
Curr Oncol Rep; 2016 Sep; 18(9):53. PubMed ID: 27469262
[TBL] [Abstract][Full Text] [Related]
6. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
[TBL] [Abstract][Full Text] [Related]
7. Quality of Life After Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharynx Cancer.
Silver JA; Bouganim N; Richardson K; Henry M; Mascarella MA; Ramirez-GarciaLuna J; Golabi N; Mlynarek AM; Zeitouni A; Hier MP; Caglar D; Esfahani K; Sadeghi N
JAMA Otolaryngol Head Neck Surg; 2024 Jan; 150(1):65-74. PubMed ID: 38060238
[TBL] [Abstract][Full Text] [Related]
8. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
[TBL] [Abstract][Full Text] [Related]
9. Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status.
Ford SE; Brandwein-Gensler M; Carroll WR; Rosenthal EL; Magnuson JS
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):606-11. PubMed ID: 25049265
[TBL] [Abstract][Full Text] [Related]
10. Oncologic outcomes of transoral robotic surgery for HPV-negative oropharyngeal carcinomas.
Parhar HS; Weinstein GS; O'Malley BW; Shimunov D; Rassekh CH; Chalian AA; Newman JG; Basu D; Cannady SB; Rajasekaran K; Lin A; Lukens JN; Swisher-McClure S; Cohen RB; Bauml JM; Aggrawal C; Brody RM
Head Neck; 2021 Oct; 43(10):2923-2934. PubMed ID: 34101290
[TBL] [Abstract][Full Text] [Related]
11. Surgical Options for Locally Advanced Oropharyngeal Cancer.
Qureshi HA; Abouyared M; Barber B; Houlton JJ
Curr Treat Options Oncol; 2019 Apr; 20(5):36. PubMed ID: 30931485
[TBL] [Abstract][Full Text] [Related]
12. The role of transoral robotic surgery in the management of oropharyngeal cancer: a review of the literature.
Dowthwaite SA; Franklin JH; Palma DA; Fung K; Yoo J; Nichols AC
ISRN Oncol; 2012; 2012():945162. PubMed ID: 22606380
[TBL] [Abstract][Full Text] [Related]
13. [The clinical value of oral robotic surgery in the treatment of oropharyngeal squamous cell carcinoma].
Zhang X; Yang ZY; Yang AK; Zhang Q; Li QL; Chen SW; Chen JT; Song M
Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):570-576. PubMed ID: 35754232
[No Abstract] [Full Text] [Related]
14. Transoral robotic surgery versus nonrobotic resection of oropharyngeal squamous cell carcinoma.
Chillakuru Y; Benito DA; Strum D; Mehta V; Saini P; Shim T; Darwish C; Joshi AS; Thakkar P; Goodman JF
Head Neck; 2021 Jul; 43(7):2259-2273. PubMed ID: 33899949
[TBL] [Abstract][Full Text] [Related]
15. Role of TORS as De-Escalation Strategy in HPV-Related Oropharyngeal Cancer, What We Need to Know.
Molteni G; Bassani S; Arsie AE; Zampieri E; Mannelli G; Orlandi E; Bossi P; De Virgilio A
Healthcare (Basel); 2024 May; 12(10):. PubMed ID: 38786424
[TBL] [Abstract][Full Text] [Related]
16. Transoral robotic surgery for oropharyngeal cancer in the era of chemoradiation therapy.
Meccariello G; Cammaroto G; Iannella G; De Vito A; Ciorba A; Bianchini C; Corazzi V; Pelucchi S; Vicini C; Capaccio P
Auris Nasus Larynx; 2022 Aug; 49(4):535-546. PubMed ID: 35101284
[TBL] [Abstract][Full Text] [Related]
17. Decision management in transoral robotic surgery: Indications, individual patient selection, and role in the multidisciplinary treatment for head and neck cancer from a European perspective.
Lörincz BB; Jowett N; Knecht R
Head Neck; 2016 Apr; 38 Suppl 1():E2190-6. PubMed ID: 25833809
[TBL] [Abstract][Full Text] [Related]
18. Transoral robotic surgery vs. radiotherapy for management of oropharyngeal squamous cell carcinoma - A systematic review of the literature.
Yeh DH; Tam S; Fung K; MacNeil SD; Yoo J; Winquist E; Palma DA; Nichols AC
Eur J Surg Oncol; 2015 Dec; 41(12):1603-14. PubMed ID: 26461255
[TBL] [Abstract][Full Text] [Related]
19. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation.
Ling DC; Chapman BV; Kim J; Choby GW; Kabolizadeh P; Clump DA; Ferris RL; Kim S; Beriwal S; Heron DE; Duvvuri U
Oral Oncol; 2016 Oct; 61():41-6. PubMed ID: 27688103
[TBL] [Abstract][Full Text] [Related]
20. Current Role of Surgery in the Management of Oropharyngeal Cancer.
Golusiński W; Golusińska-Kardach E
Front Oncol; 2019; 9():388. PubMed ID: 31179239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]